Hints and tips:
Related Special Reports
...The company is aiming to develop a wide range of drugs and use its manufacturing scale to stay ahead of pharmaceutical rivals seeking to profit from consumer “hype” for weight loss products, he added....
...with a pharmaceutical services asset, an area in which it has other investments....
...In its pharmaceutical division, Bayer had to abandon a late-stage trial for its most promising drug last year, meaning it has only a few potential blockbusters left in its pipeline: treatments for prostate...
...It is hard to see how he can climb out of the morass without selling or spinning off the company’s consumer health division, despite Bayer long resisting calls for a break-up....
...But after years of trying, the pharmaceuticals industry is getting to grips with the multibillion-dollar problem of fatty liver disease....
...The acquisition of Cardior Pharmaceuticals will give Novo Nordisk a treatment for heart failure in mid-stage trials that targets the root causes of heart disease....
...Yield was hard to find and cash was abundant, so borrowers’ lawyers were able to take the offensive, as a general rule....
...Lab monkey prices in China have plummeted as a post-pandemic slowdown in drug development ripples through the pharmaceutical sector in the world’s second-largest economy....
...A menopause-friendly employer tends to be a good overall employer in terms of supporting a range of health and wellbeing concerns.”...
...It is time to conceive a way of working as revolutionary as that described by Adam Smith, the 18th-century Scottish philosopher and economist, in his theory of the division of labour illustrated by the example...
...Investors, meanwhile, no longer have the luxury of buying into a megatrend. It is time to consider each brand’s prospects individually. camilla.palladino@ft.com...
...If we as a society are serious about women’s rights, then pharmaceutical companies and the wider global health community must ensure that mothers in the 21st century have a better chance than Kaveri of bringing...
...Children in Cameroon will begin receiving malaria vaccines as part of a rollout of the medicine developed by UK pharmaceutical company GSK in up to 12 countries across sub-Saharan Africa....
...Shares of Huadong Medicine and Hua Medicine are down a quarter in the past year, along with a broader slump in the sector as stocks normalise following a pandemic surge....
...Eli Lilly is racing to secure the services of outsourcers to boost production of its obesity drug Zepbound, as the US pharmaceutical group rolls out its rival to Danish group Novo Nordisk’s blockbuster appetite...
...Problems with supply are likely to continue as generics companies do not have a commercial interest in making older, complex drugs like alteplase and methotrexate....
...in women....
...Their daring M&A and pursuit of low-tax domiciles turned them into swashbuckling Wall Street heroes. The leader of the pack was Teva Pharmaceuticals, whose market capitalisation reached $60bn in 2015....
...Governments and industry should invest as much on preparing for pandemics as they have on Covid-19 research to avoid costly lockdowns, the chair of a body aiming to boost preparations for future health crises...
...The writer is a science commentator Four years ago this week, the World Health Organization declared the rapid spread of a new coronavirus to be a pandemic....
...Almost half of the users of these drugs did not have a history of type 2 diabetes, according to a 2023 analysis by Trilliant Health, a healthcare analytics firm....
...benefit in terms of increased access to vaccines....
...AstraZeneca has acquired oncology biotech Fusion Pharmaceuticals for $2.4bn to build its expertise and challenge Swiss company Novartis in the developing field of a more targeted form of radiotherapy....
...Goldman has made measurable progress at promoting women in recent years and women run several of its non-core divisions....
...The Department of Health said on Monday the deal would save the NHS £14bn in rebates over five years, as well as boosting the UK’s position as a global leader in life sciences....
International Edition